Marinus Pharmaceuticals, Inc.
MRNS
Revenue
8.06M
▲377.00k▲4.91%
3 Months ChangeAssets
87.08M
▼-50.27M▼-36.60%
3 Months ChangeLiabilities
134.43M
▼-19.36M▼-12.59%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-24
Form 8-K
ID: 0001558370-24-013565
2024-10-02
Form 8-K
ID: 0001558370-24-013123
2024-09-20
Form 8-K
ID: 0001104659-24-101535
2024-08-13
Form 10-Q
ID: 0001558370-24-011982
2024-08-13
Form 8-K
ID: 0001558370-24-011977
2024-06-17
Form 8-K
ID: 0001104659-24-072012
2024-06-06
Form 8-K
ID: 0001558370-24-008951
2024-05-24
Form 8-K
ID: 0001104659-24-064904
2024-05-17
Form 8-K
ID: 0001558370-24-008391
2024-05-08
Form 10-Q
ID: 0001558370-24-007187